Generic Name

MedroxyPROGESTERone Acetate

Brand Names
Depo-Provera, Depo-SubQ Provera, MedroxyPROGESTERone, Premphase, Prempro, Provera
FDA approval date: June 03, 1959
Classification: Progestin
Form: Injection, Tablet, Kit

What is Depo-Provera (MedroxyPROGESTERone Acetate)?

Depo-Provera CI is indicated for use by females of reproductive potential to prevent pregnancy. Depo-Provera CI is a progestin indicated for use by females of reproductive potential to prevent pregnancy. Limitations of Use: The use of Depo-Provera CI is not recommended as a long-term birth control method unless other options are considered inadequate. ( 1.
Save this treatment for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms

Related Clinical Trials

A Randomized Controlled Trial of Intrauterine Stent Placement Following Hysteroscopic Septum Resection

Summary: The study hopes to learn the best way to prevent internal scar tissue after septum removal. The use of an intrauterine foley catheter balloon may prevent the formation of adhesions following surgery.

Gonadotropin-releasing Hormone Agonist Combined With Letrozole Compared With Megestrol Acetate or Medroxyprogesterone Acetate Alone as Fertility-sparing Treatment in Early Endometrial Cancer

Summary: To see if Gonadotropin-releasing hormone analogue (GnRHa) combined with aromatase inhibitors (AIs) will achieve better complete response rate than megestrol acetate or medroxyprogesterone acetate (MA/MPA) alone as fertility-sparing treatment for patients with early endometrial carcinoma.

Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease

Summary: This research is being conducted to see if using an injectable contraception, Depot Medroxyprogesterone Acetate (Depo-Provera), can reduce the pain experienced by women with sickle cell disease. Participants in this study will be adult women with sickle cell disease who regularly experience sickle cell pain. They will complete a 3-month baseline with no use of hormonal contraception, and then a 3-...

Brand Information